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The development of the nervous system is a temporally and spatially coordinated process that relies on the proper regulation of the genes
involved. Neurotrophins and their receptors are directly responsible for the survival and differentiation of sensory and sympathetic
neurons; however, it is not fully understood how genes encoding Trk neurotrophin receptors are regulated. Here, we show that rat Bex3
protein specifically regulates TrkA expression by acting at the trkA gene promoter level. Bex3 dimerization and shuttling to the nucleus
regulate the transcription of the trkA promoter under basal conditions and also enhance nerve growth factor (NGF)-mediated trkA
promoter activation.Moreover, qChIPassays indicate thatBex3 associateswith the trkApromoterwithin a 150bp sequence, immediately
upstream from the transcription start site, which is sufficient to mediate the effects of Bex3. Consequently, the downregulation of Bex3
using shRNA increases neuronal apoptosis in NGF-dependent sensory neurons deprived of NGF and compromises PC12 cell differenti-
ation in response to NGF. Our results support an important role for Bex3 in the regulation of TrkA expression and in NGF-mediated
functions through modulation of the trkA promoter.
Key words: Bex3; differentiation; gene promoter; NGF; transcription; TrkA
Introduction
Nerve growth factor (NGF) was initially identified as a survival
and differentiation factor for sensory and sympathetic neurons
during development, but it has also been implicated in patholog-
ical conditions, including pain sensitivity andAlzheimer’s disease
(AD; Huang and Reichardt, 2001; Chao, 2003; Are´valo and Wu,
2006). NGF exerts its effects through two types of transmem-
brane receptors: tyrosine kinase receptor A (TrkA) and p75 neu-
rotrophin receptor (Huang and Reichardt, 2003). TrkA is mainly
expressed in the peripheral nervous system in sympathetic neu-
rons, and in nociceptive neurons in dorsal root ganglia (DRGs)
and in the trigeminal ganglia .(Martin-Zanca et al., 1990; Holtz-
man et al., 1992; Smeyne et al., 1994). During mouse develop-
ment, trkA gene expression is regulated in DRG neurons, where
expression begins at embryonic day 9.5 (E9.5), peaks at E13.5,
and remains constant throughout development (Martin-Zanca
et al., 1990).
The mouse and human trkA minimal promoters have been
characterized by in vitro reporter assays using PC12 and neuro-
blastoma cell lines, and encompass 150 bp upstream from the
transcription start site (Chang et al., 1998; Sacrista´n et al., 1999).
In vivo, a 457 bp sequence, highly conserved inmouse, chick, and
human genes, upstream from the transcription start site seems to
be required to drive coordinated trkA expression in sensory and
sympathetic neurons (Ma et al., 2000; Lei and Parada, 2007).
Several transcription factors have been reported to influence
trkA gene expression, including Sp1, Brn3a, Klf7, and Runx1
(Huang et al., 1999; Sacrista´n et al., 1999; Lei et al., 2001, 2005;
Ma et al., 2003; Marmige`re et al., 2006; Lanier et al., 2007). It
has been established that NGF treatment increases trkAmRNA
levels in PC12 cells and cholinergic neurons (Miller et al.,
1991; Holtzman et al., 1992; Li et al., 1995; Zhou et al., 1995),
and HAND transcription factors partially regulate trkA ex-
pression in response to NGF in cultured sympathetic neurons
without affecting the basal expression of trkA (i.e., in the ab-
sence of NGF; Doxakis et al., 2008). However, at present it is
unknown whether additional proteins modulate trkA gene ex-
pression in response to NGF.
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Bex3 belongs to the bex (brain-expressed x-linked) gene fam-
ily, composed of six members, bex1 to bex6 (Faria et al., 1998;
Brown and Kay, 1999; Alvarez et al., 2005). Bex3 has also been
referred to as a p75-associated death executor (NADE) and has
been shown to interact with p75 in an NGF-dependent manner,
leading to NGF-induced apoptosis (Mukai et al., 2000, 2002).
However, the function of Bex3 remains unclear as subsequent
studies did not find any link between Bex3 and p75-mediated cell
death (Tong et al., 2003; Alvarez et al., 2005).
Here we describe an unanticipated role for Bex3 in regulating
the trkA promoter. Depletion of Bex3 using shRNAdecreased the
survival of NGF-dependent neurons and impaired NGF-
mediated PC12 cell differentiation as a consequence of the spe-
cific reduction of TrkA protein and trkAmRNA levels. Reporter
assays indicated that Bex3 positively regulates basal trkA tran-
scription and that dimerization of Bex3 is required for this func-
tion. Moreover, Bex3 overexpression enhanced the induction of
trkA expression in response toNGF.Our results support a critical
role for Bex3 in TrkA receptor expression through the regulation
of the trkA promoter and, consequently, in NGF-mediated func-
tions, such as survival and differentiation.
Materials and Methods
Materials. The following antibodies were used: Trk (C-14), Bex3 (P-13),
rabbit and goat IgGs (Santa Cruz Biotechnology), GFP (Clontech),
-tubulin III (Sigma-Aldrich), phosphor (p)-Trk (Y490), phospho-Akt
and phospho-MAPK (Cell Signaling Technology), TrkA (RTA; a gift
from L. Reichardt USCF, San Francisco, CA), and Trk (203); 705 is an
antibody developed against Bex3 (see below). mNGF 2.5S was from Alo-
mone Labs. Recombinant human BDNF was from Peprotech. Leptomy-
cin B (LMB) and chloroquine were from Sigma-Aldrich. MG132 was
from Calbiochem.
Plasmids. The sequence 5-caacaaccacaaccataac-3 corresponding
to nucleotides 78–96 of rat Bex3 cDNA and the sequence 5-
caacaacaacaaccacaac-3 corresponding to nucleotides 108–126 and
78–96 ofmouse Bex3 cDNA of isoforms A and B, respectively, were used
to generate Bex3 shRNA using the pLVTHM lentiviral vector (Kim et al.,
2004). Lentivirus expressing control shRNA was generated using the
sequence 5-gcgcgctttgtaggattcg-3 from Euglena gracilis chloroplast
DNA between s16 S and 16 S rRNA. The GFP-Bex3-expressing plasmid
was constructed by inserting rat Bex3 cDNA in frame with GFP cDNA in
the pEGFP–C3 vector. The HA-Bex3-expressing plasmid was con-
structed after PCR amplification of Bex3 from the cDNA library used to
perform the yeast two-hybrid assay, sequenced, and cloned into
pcDNA3. GFP-Bex3 L90,93A; GFP-Bex3 K89R; GFP-Bex3 C117S; and
GFP-Bex3 C98S mutants were generated from the pEGFP-Bex3 plasmid
by introducing the corresponding point mutations. GFP-Bex3 D1 and
D2 were generated by introducing a TGA stop codon “in lieu” of nucle-
otides 288–290 and 178–180, respectively. A Bex3 cDNA resistant to the
action of Bex3 shRNAwas generated by site-directedmutagenesis of 5 nt
in the third codon of the wild-type (WT) Bex3 sequence recognized by
the shRNA. The sequences of the primers used for the mutagenesis were
5-gctgcaaacaacaataatcataatcacaatcacaaccacaaccac-3 and 5-gtggttgtgg
ttgtgattgtgattatgattattgttgtttgcagc-3 (the bold nucleotides indicate the
changes that were introduced in the cDNA). These changes did not
affect the amino acid sequence of the protein, but the mRNA was
resistant to Bex3 shRNA action. All constructs generated were con-
firmed by sequencing.
Yeast two-hybrid screening. A yeast two-hybrid screening performed
with the juxtamembrane region (JM) of TrkB and a cDNA library from
postnatal day 0 (P0) DRGs, as described previously (Kong et al., 2001;
Yano et al., 2001). One of the proteins identified was Bex3.
Generation of anti-Bex3 antibodies. Polyclonal antibodies against Bex3
(705) were generated in rabbits using a synthetic peptide present in rat
Bex3 protein (NNNNHNHNHNHNHNHNHNHH) coupled to keyhole
limpet hemocyanin. A first injection of 500 g of coupled peptide was
followed 3 weeks later by boosts of 200 g every 2 weeks. Bleedings were
obtained 7–10 d after the second boost. Antibodies were purified using a
CNBr Sepharose column (Pharmacia) coupledwith the synthetic peptide
used to inject the rabbits. Antibody elution was performed with 0.1 M
glycine, pH 2.5. The pH was neutralized with 1 M Tris-HCl, pH 9.0, and
the solution was supplemented with 50 mM NaCl.
In vitro pull-down assays. GST-TrkA juxtamembrane proteins were
produced in Escherichia coli, as previously described (Yano et al., 2001).
Bex3 protein was produced and labeled with 35S-Cys using the TNT
Coupled Reticulocyte Lysate System (Promega) according to the manu-
facturer’s instructions. ImmobilizedGST fusion proteins were incubated
with labeled Bex3 at 4°C. The beads were then washed extensively, and
the bound proteins were analyzed by 12% SDS-PAGE and detected by
autoradiography.
Cell cultures. HEK293 and HEK293FT cells were grown in DMEM
supplemented with 10% bovine serum, 1% nonessential amino acids
(NEAA), 2 mM L-glutamine and penicillin (pen; 100 U/ml), and strepto-
mycin (strep; 100 g/ml). Neuro2a (N2a) cells were grown in DMEM
supplemented with 10% fetal bovine serum (FBS), 1% NEAA and pen/
strep. PC12 and PC12-6/15 cells were grown in RPMI 1640 supple-
mented with 10% horse serum, 5% FBS, 2 mM L-glutamine, and pen/
strep in collagen-coated plates.
DRG and hippocampal neuron cultures. DRG neuron cultures were
performed as previously described (Yu et al., 2011). Briefly, DRGs were
dissected from E15.5 rat embryos of either sex and dissociated with
0.25% trypsin in L-15media for 45min at 37°C. Cells were centrifuged to
eliminate trypsin and resuspended in plating medium (MEM, 10% FBS,
0.4% glucose, 2 mM glutamine, 25 U/ml pen/strep). A single-cell suspen-
sionwas obtained by pipetting up anddown30 timeswith a 200l plastic
pipette tip. After counting, cells were seeded using plating medium plus
NGF (50 ng/ml) overnight on plastic plates coated with Growth Fac-
tor Reduced Matrigel (BD Biosciences) as a substrate. On the follow-
ing day, the medium was changed to neurobasal (NB) medium (B-27,
0.4% glucose, 2 mM glutamine, 25 U/ml pen/strep), NGF, and
5-fluorodeoxyuridine (2.44 g/ml) and uridine (2.44 g/ml). Prolifer-
ating cells disappeared after 3–4 d, and 95% of cells at day in vitro 8
(DIV8) were neurons.
Hippocampi were dissected from E18.5 rat embryos of either sex and
cultured as previously described (Are´valo et al., 2010). Briefly, primary
hippocampal neurons were obtained from E18–E19 rat embryos. Cells
were seeded on plating medium (MEM, 10% FBS, 0.37% glucose, 1 mM
pyruvate, 2 mM glutamine, 25 U/ml penicillin, and 25 g/ml streptomy-
cin) overnight on poly-D-lysine-coated (PDL) plates. On the following
day, the medium was changed to NB medium supplemented with B-27,
0.4% glucose, 2 mM glutamine, 25 U/ml penicillin, and 25 g/ml strep-
tomycin. Fluorodeoxyuridine (2.44 g/ml) and uridine (2.44 g/ml)
were added to kill proliferating cells.
Transfection.HEK293 cells were transfected using the calcium phos-
phate method. N2a cells, PC12 cells, and DRG neurons were trans-
fected with Lipofectamine 2000 following the manufacturer’s
recommendations.
Lentivirus generation and infection. The lentiviruses used in this study
were generated as previously described (Are´valo et al., 2010). Briefly,
HEK293FT cells were transfected with 9g of pLVTHM control shRNA,
or pLVTHM rat or mouse Bex3 shRNA, together with 6 g of psPAX2
and 5g of pMD.2G plasmids using the calciumphosphatemethod. The
medium was changed after 12 h and collected 48–72 h later. The super-
natant containing the lentiviruses was collected, centrifuged at 5000 rpm
for 15 min, filtered (45 m), and stored in aliquots at80°C. The virus
mediumwas used to infect cells, whichweremonitored by the expression
of GFP. Following infection, Bex3 levels decreased by at least 70%within
4–5 d.
Western blot analyses. Cells were lysed in lysis buffer (10 mM Tris, pH
7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 1 mM PMSF, 1 g/ml apro-
tinin, 2 g/ml leupeptin, 1 mM vanadate, 10 mM NaF, and 20 mM
-glycerophosphate) for 45 min at 4°C with gentle shaking and centri-
fuged at 14,000 g for 15min to eliminate cell debris. SDS buffer 5was
added to the lysates, and they were boiled for 7 min to denature the
proteins. Proteins were resolved by SDS-PAGE, and Western blotting
was performed with antibodies against the different proteins. To prevent
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interferences with the Ig chains, we used ProtA or ProtG conjugated with
horseradish peroxidase when the same species of antibodies were used
for both immunoprecipitation and Western blots. Quantification of the
signal bands was accomplished using ImageJ software (NIH).
Coimmunoprecipitation assays.Cells were lysed in 500l of lysis buffer
(10mMTris pH 7.4, 150mMNaCl, 2mM EDTA, 1%NP-40, 1mM PMSF,
1 g/ml aprotinin, 2 g/ml leupeptin, 1 mM vanadate, 10 mM NaF, and
20 mM -glycerophosphate) for 45 min at 4°C with gentle shaking. Ly-
sates were centrifuged at 13,000 rpm for 15 min at 4°C to eliminate
debris, and the supernatant was incubated overnight with the corre-
sponding antibody at 4°C. Protein–antibody complexes were precipi-
tated with ProtA- or ProtG-agarose, washed four times with lysis buffer,
and detected by Western blot assay.
Semiquantitative and quantitative RT-PCR.TRIzol reagent was used to
isolate total RNA from DRGs and hippocampal neurons, following the
manufacturer’s recommendations. cDNA was synthesized with 1 g of
RNAand reverse transcribed using the ImProm-II Reverse Transcription
System and random primers. The cDNA concentration was determined
by measuring absorbance with a Nanodrop 2000c (Thermo Scientific).
For semiquantitative PCR, the relative amounts of cDNA and the range
of PCR cycles that permit the linear amplification of bex3 (35 cycles) and
-actin (20 cycles) were determined. The primer sequences were as
follows: 5-agccatgtacgtagccatcc-3 and 5-accctcatagatgggcacag-3 for
-actin (used as a control); and 5-cattcccaacaggcagatg-3 and 5-
ggcataaggcagaattcatc-3 for rat and mouse bex3. The PCR conditions for
bex3 were as follows: 94°C for 30 s, 58°C for 30 s, followed by 72°C for
40 s. Using the NIH ImageJ software, each DNA band was tested for its
relative band intensity. The relative expression of bex3mRNA was eval-
uated by calculating the bex3/-actin signal ratio. Quantitative PCRs
(qPCRs) were performed in triplicate using SYBR-Green Power Master
Mix (Applied Biosystems). ThemRNA level of each genewas normalized
using -actin as a reference. The oligonucleotides used to amplify trkA
(Ntrk1 reference NM_021589.1, with an efficiency of 106%) were 5-
tctccttctcgccagtggac-3and 5-acagccacagagaccccaaa-3 for full-length
trkB (Ntrk2 transcript variant 1 reference NM_012731.2, with an effi-
ciency of 104.5%), were 5-ccggacacatttgttcagca-3and 5-ttccca
aaggctccttctcc-3 for -actin (Actb reference NM_031144.3 with an
efficiency of 107%), and were the same as those used in the semiquanti-
tative RT-PCR. An ABI Prism 7300 detection system (Applied Biosys-
tems) was usedwith the following conditions: 2min at 50°C, then 10min
at 95°C followed by 40 cycles of 15 s at 95°C and 1min at 61.5°C. Follow-
ing amplification, the melting curves for the products were generated to
ensure that a product represented a homogenous species. A comparative
cycle of threshold fluorescence (Ct) was used, and the relative transcrip-
tion level of the target gene was normalized to that of -actin using the
2Ct method.
DRG neuron survival. NGF-dependent rat DRG neurons were trans-
fected at DIV4–5 with the corresponding plasmids expressing GFP using
Lipofectamine 2000 (Invitrogen). The following day, the medium was
replaced, keeping the NGF for 24 h, after which it was removed. Trans-
fected cells were recognized by GFP expression, and apoptotic neurons,
identified by fragmented or condensed nuclei usingHoechst 33342 stain,
were scored 48–72 h after NGF withdrawal. Images were taken in ran-
dom selected fields using a Leica DMI3000Bmicroscope equipped with a
Leica DFC300FX camera.
In situ hybridization and immunocytochemistry. Plasmids containing
specific probes for mouse trkA (nucleotides 19–219 of Ntrk1 reference
NM_001033124) and mouse bex3 (nucleotides 251–449 of bex3 ref
NM_009750) were used to synthesize digoxigenin-labeled antisense
riboprobes according to the supplier’s instructions (Roche). bex3 and
trkA riboprobes were used at final concentrations of 1 and 0.5 g/ml,
respectively.
Mouse embryos were obtained at different embryonic days consider-
ing the day the plug was observed as E0.5. Embryos were placed in 4%
paraformaldehyde (PFA) in 0.1 M PB for 24 h. On the following day, they
were placed in 4% PFA plus 20% sucrose in 0.1 M PB and then in 30%
sucrose until they sank. Tissue sections (12 m) were obtained. For in
situ hybridization, sections were postfixed with 4% PFA for 10 min,
treated with PBS containing 0.1% DEPC for 5 min, and then with PBS
containing 20 g/ml proteinase K for 6 min, followed by acetylation for
10min. Sections were prehybridized for 30min and then hybridizedwith
the corresponding probe overnight at 55°C. On the next day, sections were
rinsed with 5 SSC at 65°C, washed with 2 SSC/50% formamide for 30
min at 65°C, treated with 20g/ml RNase for 30 min at 37°C, washed with
2 SSC and 0.1 SSC, and subjected to anti-DIG-AP-conjugated antibody
(Roche) staining and a BCIP/NBT (Roche) color reaction.
When in situ hybridization and immunocytochemistry were per-
formed on the same section, the immunocytochemistry was done first.
Sectionswere postfixedwith 4%PFA for 10min, washed three timeswith
PBS, and preblocked in PBS with 5%NGS and 0.1% Triton X-100 for 30
min. Sections were incubated overnight at 4°C with RTA antibody that
specifically recognizes TrkA. On the following day, sections were rinsed
three times with PBS, incubated for 1 h at room temperature with Alexa
Fluor 488 (Invitrogen), and rinsed three times with PBS. Then, in situ
hybridization was performed as described above, using anti-DIG-
rhodamine-conjugated antibody (Roche) to detect bex3. Images were
collected with a Leica confocal microscope.
Reporter assays.N2aor PC12 cells growing in 12-well plateswere trans-
fected using Lipofectamine 2000. The plasmids used were pEGFP,
pEGFP-Bex3, pEGFP-Bex3 mutants, control shRNA, and Bex3 shRNA
(1.5 g), and the corresponding trkA promoter constructs (0.5 g) were
pMS8, pMS10.3, pMS16, and pMS22, which have been described previ-
ously (Sacrista´n et al., 1999). After 48 h, cell extracts from transfected
cells were prepared, and CAT protein ELISA analyses were performed in
duplicate using a CAT ELISA kit (Roche). CAT was measured using an
LT-4000 microplate reader (LabTech) at 405 nm. Western blot analyses
were performed to ensure that the expression levels were similar.
Immunofluorescence.TheHEK293 cells used to detect GFP-Bex3 local-
ization were cultured on coverslips coated with 1 mg/ml PDL. After
transfection with the corresponding expression vector, cells were treated
or notwith Leptomycin B for 6 h, fixedwith 4%PFA in PBS for 5min and
washed three times for 5 min. Coverslips were mounted in Vectashield
medium (Vector Laboratories).
Nuclear fractionation. PC12-6/15 cells were stimulated or not with
NGF (100 ng/ml) for 15 min, washed with cold PBS, and then lysed with
cytoplasmic lysis buffer (10 mM HEPES, pH 7.5, 1.5 mM MgCl2, 10 mM
KCl, 1 mM EDTA, 0.1%NP-40, 1 mM PMSF, 1g/ml aprotinin, 2g/ml
leupeptin, 1 mM vanadate, 10 mM NaF, and 20 mM -glycerophosphate)
by pipetting up and down several times. Then, nuclei were pelleted by
centrifugation at 500 g for 10min at 4°C. The nuclei were washed with
cytoplasmic lysis buffer to remove any contaminating cytoplasm, and
pelleted again. The nuclei were lysed with complete lysis buffer (50 mM
HEPES pH7.5, 1.5mMMgCl2, 10mMKCl, 10mMNaCl, 1mMEDTA, 1%
NP-40, 1 mM PMSF, 1 g/ml aprotinin, 2 g/ml leupeptin, 1 mM vana-
date, 10mMNaF, and 20mM-glycerophosphate). Finally, proteins were
quantified, andWestern blots were performed. p-Histone3 was used as a
nuclear marker.
Chromatin immunoprecipitation assays.N2a cells were grownon 10 cm
plates to confluence and then treated with 1% formaldehyde for 10 min
at 37°C. Cells were washed with cold PBS twice, pelleted (3500 rpm, 4°C,
5 min), and lysed with SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM
Tris-HCl, pH8.0, andprotease inhibitors) for 10min at 4°C. Lysateswere
sonicated using an ultrasonic bath (USC100, VWR) and centrifuged at
13,000 rpm for 10min at 4°C, and the supernatant was diluted 10-fold in
chromatin immunoprecipitation (ChIP) dilution buffer (0.01% SDS,
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.0, 167 mM
NaCl, and protease inhibitors). For later input, 1% of the diluted super-
natant was saved. The remaining supernatant was precleared with pro-
tein G-Plus Agarose for 1 h at 4°C with constant shaking. Chromatin was
immunoprecipitated with 4 g of normal goat IgG or Bex3 antibody
(P-13) previously cross-linked with protein G-Plus Agarose overnight at
4°C. Complexes were washed sequentially with the following buffers and
centrifuged at 2000 rpm for 3 min at 4°C: 2 low-salt buffer (0.1% SDS,
1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 150 mMNaCl);
2 high-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris-HCl, pH 8.0, 500 mM NaCl); and 2 TE buffer. The immunopre-
cipitated complexes were eluted with 2 250 l elution buffer (1% SDS,
0.1 M NaHCO3), and cross-linking was reversed by the addition of 20 l
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of 5 M NaCl and subsequent incubation for 5 h at 65°C. Then 10l of 0.5
M EDTA, 20 l of 1 M Tris-HCl, pH 6.5, and 1 l of 20 mg/ml proteinase
K were added to the eluate, and incubated for 1 h at 45°C. The DNA was
recovered by phenol/chloroform extraction. For N2a cell experiments,
PCR was performed for 35 cycles at 94°C for 30 s, at 55°C for 30 s, and at
72°C for 30 s. The oligonucleotides used to amplify the trkA promoter
were 5-cgtgagggacatgaggaag-3 and 5-gggcggtgttaaagactagc-3. Ampli-
fied products were detected by standard 2% agarose gel electrophoresis.
For PC12 cell experiments, immunoprecipitations were performed as
described above, but quantitative PCR was performed instead of PCR.
Input and ChIP samples were analyzed by triplicate using SYBR Green
fluorescence (ABI Prism 7300 detection System and Power SYBR Green
Master Mix; Applied Biosystems). The detection system was used with
the following conditions: 2min at 50°C, then 10min at 95°C, followed by
40 cycles of 15 s at 95°C and 1 min at 58°C. Following amplification, the
melting curves for the products were generated to ensure that a product
represented a homogenous species. The fragment amplified in both pro-
cedures is located in the promoter region described previously (Sacrista´n
et al., 1999) between nucleotides143 and19, numbered with respect
to the main trkA transcriptional start site. The relative fold difference of
the amplified fragment was calculated relative to a control using the
Ct method.
Statistics.Results are expressed as themean SEM. Statistical analyses
were performed with GraphPad Prism version 4.
Results
Bex3 interacts with Trk neurotrophin receptors
To identify proteins that interact with the Trks, a yeast two-
hybrid screen was performed using a P0 rat DRG library and the
juxtamembrane domain of TrkB receptor as a bait (Kong et al.,
2001; Lou et al., 2001; Yano et al., 2001). Bex3 was identified once
among the 75 positive clones obtained. Considering thatmost rat
DRG neurons at P0 are TrkA positive (Bennett et al., 1996; Benn
et al., 2001; Guo et al., 2001), we assessed whether there was an
association between Bex3 and TrkA. By performing coimmuno-
precipitation assays in HEK293 cells transfected with plasmids
expressing both proteins, we observed an interaction between
them (Fig. 1A). In addition, endogenous Bex3 interacted with
TrkA in PC12–6/15 cells both in the presence and in the absence
of NGF (Fig. 1B,C). Furthermore, TrkA and Bex3 association
was also observed in embryonic rat DRG neurons (Fig. 1D).
These findings indicate that Bex3 interacts with theNGF receptor
TrkA. Tomap the region of TrkA involved in this interaction, we
performed in vitro pull-down assays using GST fusion proteins
containing different fragments of the TrkA juxtamembrane re-
gion (Yano et al., 2001; Fig. 1E, left) and in vitro translated Bex3
protein. The results showed that all GST-TrkA protein fragments
interacted with Bex3 (Fig. 1E, right). To determine whether Bex3
could bind to other domains of TrkA, a mutant TrkA lacking the
JM was used (Are´valo et al., 2004). Coimmunoprecipitation
experiments showed that Bex3 did not interact with any other
domains of TrkA aside from the juxtamembrane domain (Fig.
1F). Next, we examined which regions of Bex3 were involved in
the interaction with TrkA by performing coimmunoprecipita-
tion experiments in HEK293 cells transfected with TrkA and
different Bex3 constructs. The deletion mutants Bex3-D1 and
Bex3-D2, respectively lacking 33 and 73 aa of the C terminus of
Bex3, failed to interact with TrkA, whereas the Bex3 proteins
carrying L90,93A and C117S mutations, which disrupt the nu-
clear export sequence (NES) and CAAX motifs, respectively,
showed reduced binding to TrkA (Fig. 1G). Notably, a point
mutation in the C terminus of Bex3 that replaced lysine 89 by
arginine, within a destruction box (D-box; Mukai et al., 2000),
did not affect the interaction with TrkA (Fig. 1G). These data
support the notion that the interaction between Bex3 and TrkA is
mediated through the juxtamembrane region of TrkA and the C
terminus of Bex3.
trkA and bex3 are coexpressed in most DRG neurons
during development
To study the biological significance of Bex3 interaction with
TrkA, we investigated the expression pattern of trkA and bex3 in
mouse DRG neurons by in situ hybridization during develop-
ment. bex3 and trkAmRNA expressionwere observed inDRGs at
E11.5 and E12.5 (Fig. 2A). To address whether bex3 mRNA and
TrkA protein were present in the same neurons, we simultane-
ously performed in situ hybridization for bex3mRNAand immu-
nohistochemistry for TrkAprotein, using an antibody (RTA) that
specifically recognizes TrkA, but not other Trk neurotrophin re-
ceptors (Clary and Reichardt, 1994). DRG neurons expressing
bex3 mRNA also expressed TrkA protein (Fig. 2B). These data
therefore demonstrate that bex3 mRNA and TrkA protein are
coexpressed in most DRG neurons during development.
Bex3 protein levels modulate the survival of NGF-dependent
DRG neurons and the differentiation of PC12 cells in
response to NGF
To identify the potential roles for Bex3 in NGF/TrkA-dependent
functions, we assessed the consequences of Bex3 depletion using
shRNA in the survival of NGF-dependent DRG neurons and in
the differentiation of PC12 cells. First, we tested bex3 mRNA
levels in DRG neurons infected with lentivirus expressing either
GFP and control shRNA or GFP and Bex3 shRNA (Fig. 3A, left).
bex3 mRNA was efficiently downregulated in response to Bex3
shRNA (67%; Fig. 3A, right). Consequently, Bex3 protein levels
were decreased in DRG neurons infected with Bex3 shRNA len-
tivirus (Fig. 3B). We then assessed the survival of NGF-
dependentDRGneurons in response to Bex3 depletion. Cultured
sensory neurons were transfected with plasmids that expressed
either GFP and control shRNA or GFP and Bex3 shRNA. The
presence of GFP allowed transfected neurons to be identified
unambiguously. The quantification of apoptotic cells was per-
formed 48–72 h after NGF withdrawal (Fig. 3C, left), showing
that Bex3 depletion significantly increased apoptosis in NGF-
dependent neurons (72%; Fig. 3C, right). These findings
indicate that Bex3 protein reduction accelerates apoptosis of
NGF-deprived sensory neurons.
To address whether Bex3 also participates in neuronal differ-
entiation in response to NGF, we infected PC12 cells with lenti-
virus expressing either GFP and control shRNA or GFP and Bex3
shRNA. Four days postinfection, cells were treated with NGF
(100 ng/ml) for 72 h and images of GFP-positive cells were ob-
tained (Fig. 3D, left). Quantification of neurite outgrowth
showed that Bex3 depletion significantly decreased the percent-
age of differentiated cells in response to NGF (59%; Fig. 3D,
right). These results indicate that Bex3 levels modulate the differ-
entiation of PC12 cells in response to NGF.
To explore how Bex3 regulates NGF-mediated survival and
differentiation, we assessed the signaling pathways activated by
NGF in sensory neurons infected with control or Bex3 shRNA
lentivirus. We observed that the levels of phosphorylated TrkA,
Akt, and MAPK proteins in response to NGF were reduced in
neurons infected with Bex3 shRNA lentivirus (Fig. 3E). This was
correlated with a clear reduction in total TrkA protein levels in
Bex3-depleted neurons (Fig. 3E). Together, these data demon-
strate that Bex3 regulates neuronal survival and differentiation,
likely by altering NGF-dependent signaling pathways as a conse-
quence of TrkA protein level modulation.
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Bex3 downregulation reduces TrkA, but not TrkB, protein
levels by decreasing trkAmRNA levels
To further confirm that Bex3 specifically modulated TrkA pro-
tein levels, we depleted Bex3 from DRG neurons and found that
TrkA levels were significantly reduced (76%; Fig. 4A). The re-
duction of TrkA protein levels in cells with Bex3 knocked down
might have been caused by increased ubiquitin-mediated degra-
dation of TrkA. Indeed, it has been shown that Bex3 inhibits
Figure 1. Bex3 interacts with TrkA neurotrophin receptor. A, TrkA and Bex3 interact in HEK293-transfected cells. Lysates from HEK293 cells cotransfected with TrkA and HA-Bex3 were
immunoprecipitatedwith Trk antibody (203) andWesternblotswereperformed todetect thepresenceofBex3 (HA) andTrk in the immunoprecipitates. Theexpressionof TrkAandBex3 in the lysates
was detected with the corresponding antibodies. B, Endogenous Bex3 interacts with TrkA in PC12–6/15 cells. PC12–6/15 cell lysates were subjected to immunoprecipitation using Trk antibody
(C-14) or rabbit-IgG as a control.Western blotswere performed to detect the presence of Bex3 and Trk in the immunoprecipitates. C, Bex3 interactswith TrkA in PC12–6/15 cells in the presence and
in the absence of NGF. PC12–6/15 cells were treated, or not, with NGF (100 ng/ml) for 15 min, and lysates were immunoprecipitated with Bex3 antibody (P-13). Western blots were performed to
detect thepresenceof TrkAandBex3 in the immunoprecipitates. Theexpressionof TrkAandBex3 in the lysateswasdetectedwith the correspondingantibodies.D, TrkAandBex3 interact in ratDRGs.
DRGs were dissected from E15.5 rat embryos and lysed for 2 h at 4°C. The lysates were immunoprecipitated with Trk antibody (203) or rabbit-IgG as a control, andWestern blots were performed to
detect the presence of Bex3 and Trk in the immunoprecipitates. E, The TrkA juxtamembrane domain participates in the interaction with Bex3. GST-TrkA recombinant proteins (left) were incubated
with S 35-labeled Bex3 and resolved in SDS-PAGE. Autoradiography was performed to detect the interaction, and Coomassie staining was used to check GST fusion protein levels (right). F, Bex3
interacts exclusivelywith the juxtamembrane region of TrkA. Lysates fromHEK293 cells cotransfectedwith GFP-Bex3 and TrkA or TrkA-JMwere immunoprecipitatedwith Trk antibody (203), and
Western blots were performed to detect the presence of Bex3 (GFP) and TrkA (RTA) in the immunoprecipitates and lysates. Arrow indicates GFP-Bex3, and asterisks indicate a nonspecific band. G,
The C terminus of Bex3 mediates its interaction with TrkA. TrkA and GFP-fused Bex3 expression plasmids (left) were cotransfected in HEK293 cells, and lysates were immunoprecipitated with Trk
antibody (203). TrkA-interactingBex3wasdetectedusingGFPantibodies. ImmunoprecipitatedTrkAandBex3 levels in the lysatesweredetectedwith the correspondingantibodies (right). Actinwas
used as a loading control.
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Smac ubiquitination, affecting the stability of the protein (Yoon
et al., 2004). To address whether Bex3 protein regulates TrkA
ubiquitination, Bex3 and TrkA were expressed in HEK293 cells.
No differences in TrkA ubiquitination were observed in the pres-
ence or absence of Bex3 (Fig. 4B). We also examined TrkA levels
in DRG neurons infected with control or Bex3 shRNA in the
presence of lysosome and/or proteasome inhibitors. TrkA levels
were not rescued in the presence of any of the inhibitors when
Bex3 was depleted (Fig. 4C). Therefore, the reduction of TrkA
protein levels elicited by Bex3 downregulation is not the result of
increased protein degradation.
To assess whether trkAmRNA levels weremodulated by Bex3,
total mRNA was obtained from infected DRG neurons, and its
levels were measured by qPCR. A reduction in trkAmRNA levels
was observed in Bex3-depleted DRG neurons (52%; Fig. 4D).
These data suggest that Bex3 regulates TrkA at the level of mRNA
expression.
To determine whether the effects of Bex3 were specific for
TrkA, we examined cultured hippocampal neurons, which
express TrkB, but not TrkA, and Bex3 endogenously (Kendall et
al., 2003). Neurons infected with lentivirus expressing Bex3
shRNA showed reduced levels of bex3 mRNA (55%; Fig. 4E).
TrkB protein levels were tested using Western blot (Fig. 4F, left).
The quantification of several experiments did not reveal signifi-
cant differences in TrkB protein levels in response to Bex3 deple-
tion (Fig. 4F, right). Furthermore, trkB mRNA levels were not
affected by Bex3 reduction in hippocampal neurons (Fig. 4G).
Together, these data demonstrate that
Bex3 levels specifically modulate TrkA
protein through the regulation of trkA
mRNA levels.
Bex3 shuttles between the cytoplasm
and the nucleus
It has been described that Bex3 is located
in the cytoplasm (Mukai et al., 2000; Al-
varez et al., 2005). Since Bex3 protein has a
NES, we tested whether Bex3 shuttles be-
tween the cytoplasm and the nucleus by
performing immunofluorescence analy-
ses. HEK293 cells transfected with GFP-
Bex3 showed cytoplasmic staining (Fig.
5A, top panels), whereas the Bex3 mutant
L90,93A, with a disrupted NES, exhibited
mainly a nuclear localization (Fig. 5A,
bottom panels). To address whether WT
Bex3 was actively excluded from the nu-
cleus, we treated transfected cells with lep-
tomycin B, an inhibitor of nuclear export
through CRM1 (Fornerod et al., 1997).
Indeed, GFP-Bex3 was mainly located in
the nucleus in the presence of leptomycin
B (Fig. 5B, top panels). As a control of the
specificity of the action of leptomycin B,
we monitored the localization of GFP-
ARMS, a protein without NES. GFP-
ARMS was not accumulated in the
nucleus in the presence of leptomycin B
(Fig. 5B, bottom panels). Accordingly,
Bex3 shuttles between the cytoplasm and
the nucleus, and is actively excluded from
the nucleus through its NES motif.
Bex3 dimerization enhances transcriptional activity of the
mouse trkA gene promoter
Our results demonstrated that Bex3 protein regulated trkA
mRNA levels (Fig. 4B). To assess whether Bex3 controlled the
transcriptional activity of the trkA promoter, we performed re-
porter assays using N2a cells, which express Bex3 and have been
used previously tomap themouse trkA promoter (Sacrista´n et al.,
1999). First, we transfected N2a cells with the reporter construct
pMS8 (see Materials and Methods; Sacrista´n et al., 1999) and a
plasmid that expresses control or Bex3 shRNA (Fig. 6A, top).
Bex3 depletion reduced trkA promoter activity significantly
(36%; Fig. 6A, bottom). To determine whether the Bex3
shRNA-induced phenotype was directly attributable to the
specific knockdown of Bex3 and not to the off-target effects of
the shRNA, a rescue experiment was performed. We designed
a GFP-fused Bex3 coding sequence harboring multiple silent
mutations that rendered the resulting bex3mRNA resistant to
shRNA knockdown (GFP-Bex3-resistant; see Materials and
Methods). The expression of this mRNA not only rescued the
effect of endogenous Bex3 depletion but also induced a signif-
icant increase in the transcriptional activity of the trkA pro-
moter above basal levels (103%; Fig. 6A, bottom). These
findings indicate that the observed decrease in the transcrip-
tional activity of the trkA promoter in response to Bex3
shRNA is a result of the specific knockdown of Bex3 and sug-
gest that the overexpression of Bex3 enhances trkA promoter
activity.
Figure 2. Developmental expression pattern of bex3 and trkA. A, In situ hybridization with bex3 and trkA probes performed in
consecutive sectionsof E11.5 andE12.5mouseembryos. Scalebar, 100m.B, Coexpressionofbex3mRNAandTrkAproteinduring
mouse DRG development. Immunofluorescence for TrkA and in situ hybridization for bex3 mRNA at E11.5 and E13.5. Note the
colocalization of bex3mRNA and TrkA in the same cells. Scale bar, 100m.
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To further address the involvement of
Bex3 in the transcriptional activation of
the trkApromoter, we performed reporter
assays using different Bex3 expression
constructs. Transfection of a plasmid ex-
pressingWT Bex3 fused to GFP increased
trkA promoter activity (89%; Fig. 6B).
Disruption of the nuclear export sequence
(Bex3 L90,93A) or deletion of the C ter-
minus (Bex3 D1 and Bex3 D2mutants) of
Bex3 abolished the enhancing effect
caused by WT Bex3 (Fig. 6B). A Bex3
K89R mutant, which disrupts the D-box,
showed the same activity asWTBex3; sur-
prisingly, Bex3 C117S, which disrupts the
CAAX motif, displayed enhanced activity
compared with WT Bex3 (195%; Fig.
6B). Expression levels of each protein
were similar, as determined by Western
blot analyses. In addition, we observed the
presence of oligomers (dimers and te-
tramers) of GFP-Bex3, GFP-Bex3 K89R,
and GFP-Bex3 C117S (Fig. 6C). The pres-
ence of oligomers was directly correlated
with the increased trkA promoter activity
elicited by the expression of these Bex3
proteins (Fig. 6B,C). Furthermore, the
GFP-Bex3 D1, D2, and L90,93A mutants,
which failed to increase trkA promoter ac-
tivity (Fig. 6B), did not show or had
greatly reduced numbers of oligomers,
despite being expressed at similar or even
higher levels than WT Bex3 (Fig. 6C).
Together, these data indicate that Bex3 C
terminus is necessary to enhance trkA
promoter transcription and that oli-
gomerization of Bex3 might be required
for this function.
To determine the requirement of Bex3
oligomerization, we took advantage of a
previously described Bex3 mutant (C98S)
that does not dimerize due to the lack of a
disulfide bond (Kimura et al., 2001). First,
we confirmed that Bex3 C98S did not
dimerize (Fig. 6D, left). Reporter assays
showed reduced capability of Bex3 C98S
to induce trkA promoter transcription
compared withWTBex3 (60%; Fig. 6D,
right). These results support a role of Bex3
dimerization in enhancing trkA promoter
activity.
Toassess thephysiological consequences
of overexpressing different Bex3 proteins,
we performed functional assays. First, we
analyzed the effect of ectopic expression of
Bex3proteinsonPC12celldifferentiation in
response to NGF. An increase in neurite
outgrowth was observed with GFP-Bex3-
expressing cells compared with GFP cells (41%), whereas the ex-
pression of GFP-Bex3 L90,93A, which is mainly nuclear, or GFP-
Bex3C98S,whichdoesnot dimerize, had no effect (Fig. 6E). In the
absence of NGF, the expression of none of the Bex3 proteins
evoked a response. These results suggest that the overexpression
of WT Bex3 potentiates PC12 differentiation and that nuclear–
cytoplasmic shuttling and dimerization of Bex3 play an impor-
tant role in neurite outgrowth. Additionally, we assessed survival
in NGF-dependent sensory neurons. Interestingly, GFP-Bex3
and GFP-Bex3 C98S overexpression enhanced the percentage of
Figure 3. Bex3 protein levels modulate the survival of NGF-dependent neurons and the differentiation of PC12 cells. A, bex3
mRNA downregulation in DRG neurons by shRNA. Cultured DRG neuronswere infected at DIV5with lentivirus-expressing GFP and
control shRNA (c) or GFP and Bex3 shRNA (b). RNA was obtained 5 d later, and semiquantitative RT-PCRs were performed as
described in Materials and Methods. Actin was used as a control. Two representative RT-PCR experiments are shown (left).
Quantification of bex3 and actinmRNAwas performed using ImageJ software (right). The intensity of the DNA bands was quanti-
fied and normalized to that of actin in the control (100%vs 33.1 5.9%, control vs Bex3 shRNA, respectively). Data are presented
as themean SEM (n	 7). The p valuewas calculated using a two-tailed Student’s t test.B, Bex3 protein downregulation inDRG
neurons. Cultured DRG neurons were infected as described in A, and extracts were obtained to analyze Bex3 protein by Western
blot. A representativeWestern blot showing a decrease in Bex3 protein is depicted. Tubulin was used as a loading control. Arrows
indicate Bex3monomer and dimer. C, Bex3 protein levels modulate the survival of NGF-dependent neurons in vitro. Cultured DRG
neurons were transfected with plasmids expressing either GFP and control shRNA (c) or GFP and Bex3 shRNA (b). Neurons were
deprived of NGF for 48–72 h and stained with Hoechst 33342, indicating which ones were apoptotic (red arrowhead) or non-
apoptotic (white arrowhead) within GFP-positive population. Left, Representative images of NGF-dependent DRG neurons trans-
fected with control or Bex3 shRNA plasmids. Scale bar, 10m. Right, Quantification of apoptosis in GFP-positive cells. Data are
shown as the mean SEM. The total number of quantified neurons was 249 and 464 in control and Bex3 shRNA-transfected
groups respectively from four independent experiments (16.83.1%vs28.92.8%, control vs Bex3 shRNA, respectively; right).
The p value was calculated using a two-tailed Student’s t test. D, Bex3 downregulation impairs neurite outgrowth of PC12. Cells
were infectedwith lentivirus expressingGFPand control shRNA (c) orGFPandBex3 shRNA (b) for 5d, and then stimulatedwithNGF
(100ng/ml) for 72h. Scalebar, 10m.Neurite outgrowthwasquantifiedbyassessing thepercentageofGFP-positive cells bearing
neurites at least twice the length of the cell body. Data are shown as themean SEM. The total number of cells in the control and
Bex3 shRNA-infected groups were respectively 204 and 210 from four independent experiments (32.5 6.5% vs 19.3 6.1%,
control vs Bex3 shRNA, respectively). The p valuewas calculated using a two-tailed Student’s t test. E, The downregulation of Bex3
impairs NGF-mediated signaling pathways in DRG neurons. DRG neurons were infected as indicated in A, and 5 d later they were
treated with NGF (100 ng/ml) for 1 h. Cell extracts were obtained, and active TrkA, Akt, andMAPKwere assessed using antibodies
that recognize specific phosphorylated residues. Representative blots are shown (n	 6).
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apoptotic neurons deprived of NGF compared with GFP overex-
pression (56% and 61%, respectively; Fig. 6F). On the con-
trary, the overexpression of GFP-Bex3 L90,93A did not promote
apoptosis further than GFP overexpression. These data suggest
that overexpression and nuclear–cytoplasmic shuttling of Bex3
evokes an apoptotic response in the absence of NGF.
Bex3 binds to the mouse trkAminimal promoter
To identify the region of the trkA promoter where Bex3 exerts its
function, we used several trkA reporter constructs (Fig. 7A, top).
Previously it has been reported that plasmids pMS10.3 and
pMS16 containing 934 and 150 bp, respectively, upstream from
the transcription start site, display transcriptional activity similar
Figure 4. Bex3 levels regulates TrkA, but not TrkB, protein levels throughmodulation of trkAmRNA. A, TrkA protein levels are reduced in DRG neurons upon Bex3 downregulation. Cultured DRG
neuronswere infected as described in Figure 3A, and cell extractswere obtained to analyze TrkA expression byWestern blot. Tubulinwas used as a loading control. Two representativeWestern blots
are shown (left). Quantification of TrkA levels in response to Bex3 downregulation (right). Western blots were scanned and quantified using ImageJ software. Data were normalized to the amount
of tubulin and are presented as the mean SEM (100% vs 24.1 5.1%, control vs Bex3 shRNA, respectively; n	 7). The p value was calculated using a two-tailed Student’s t test. B, GFP-Bex3
expression does not affect TrkA ubiquitination. HEK293 cells were transfected with TrkA and different amounts of GFP-Bex3. TrkA was immunoprecipitated 24 h after transfection, and TrkA
ubiquitination levels were assessed by Western blot. A representative experiment is shown (n	 3). Arrows indicate GFP or GFP-Bex3. C, Bex3 levels do not alter TrkA degradation. Cultured DRG
neuronswere infected at DIV5with control shRNA (C) or Bex3 shRNA (B) lentivirus for 5 d, and then treatedwith chloroquine (10M), MG132 (50M), or both for 0, 3, or 6 h.Western blot analyses
were performed to detect TrkA levels. A representative experiment is shown (n	 3).D, Bex3 downregulation decreases trkAmRNA levels. CulturedDRGneuronswere infected as described in Figure
3A. RNAwas obtainedwith TRIzol reagent, cDNAwas synthesized, andquantitative PCRwas performed as described inMaterials andMethods. The relative transcription level of trkAwasnormalized
to that of actin using the 2 -Ctmethod. Data are presented as themean SEM (1.10 0.1 vs 0.57 0.1, control vs Bex3 shRNA, respectively). Triplicate determinations from three independent
experiments were quantified. The p value was calculated using a two-tailed Student’s t test. E, bex3 mRNA downregulation in hippocampal neurons infected with lentivirus-expressing rat Bex3
shRNA. Experiments using cultured hippocampal neuronswere performed andquantified in a similarway as described in Figure 3A. Data are presented as themean SEM (100%vs 45.0 11.4%,
control and Bex3 shRNA, respectively; n	 4). The p value was calculated using a two-tailed Student’s t test. F, TrkB protein levels are not altered upon Bex3 downregulation. Extracts from
hippocampal neurons infected with control shRNA (c) or Bex3 shRNA (b) lentivirus were analyzed for TrkB expression. Tubulin was used as a loading control. Two representative Western blots are
shown (left). TrkB levels (right) were quantified, as described in A. Data are shown as themean SEM (100% vs 124.0 23.9%, control and Bex3 shRNA, respectively; n	 4). The p value
was calculated using a two-tailed Student’s t test. G, Downregulation of Bex3 does not affect trkBmRNA. RNAwas obtained from infected hippocampal neurons, and qPCR was performed
as described in D. Data are shown as the mean SEM (1.0 0.06 vs 0.98 0.20, control and Bex3 shRNA, respectively). Triplicate determinations from three independent experiments
were quantified.
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to pMS8, whereas pMS22, which only includes 43 bp upstream
from the start site, has no transcriptional activity (Sacrista´n et al.,
1999). Bex3 overexpression enhanced the transcriptional activity
of pMS8, pMS10.3, and pMS16 to a similar extent, whereas
pMS22 did not show any activity in response to Bex3 expression
(Fig. 7A, bottom). Thus, Bex3 modulation of the trkA promoter
activity requires the 150 bp sequence upstream from the trkA
transcription start site. To assess whether Bex3 was associated
with this sequence, we performed ChIP assays in N2a cells. Upon
endogenous Bex3 immunoprecipitation, PCR assays yielded a
DNA fragment extending from nucleotide143 to19 that was
not observed when control IgGs were used (Fig. 7B). Further-
more, these data were confirmed in PC12 cells using qChIP as-
says. A sevenfold increase in trkApromoter sequence amountwas
observed when endogenous Bex3 protein was immunoprecipi-
tated compared with control conditions (Fig. 7C). Thus, Bex3
binds to trkA promoter sequences within a 150 bp region up-
stream from the transcription start site.
Bex3 enhances the transcriptional activation of the trkA
promoter in response to NGF
It has previously been reported that NGF increases trkA expres-
sion in PC12 cells and in cholinergic basal forebrain neurons
(Miller et al., 1991; Holtzman et al., 1992; Li et al., 1995; Zhou et
al., 1995). To address whether Bex3 potentiates NGF-mediated
trkA transcriptional activity, we performed reporter assays in
PC12 cells. GFP or GFP-Bex3 plasmids were cotransfected with
pMS8 in PC12 cells to assess trkA promoter activity in response to
NGF. The basal trkA promoter activity (i.e., in the absence of
NGF) was enhanced in PC12 cells overexpressing GFP-Bex3
(60%; Fig. 8A), an effect similar to that observed in N2a cells
(Fig. 6A,B).No increase in promoter activation above basal levels
was detected after 30 min of NGF treatment in GFP- or GFP-
Bex3-expressing PC12 cells (Fig. 8A). NGF treatment for 18 h in
GFP-transfected cells led to an increase in the activation of the
trkA promoter compared with nonstimulated cells (22%; Fig.
8A), which is in agreement with previous reports (Miller et al.,
1991; Zhou et al., 1995). Furthermore, Bex3 overexpression in
PC12 cells stimulatedwithNGF for 18 h elicited an increase in the
activation of the trkA promoter compared with nonstimulated
cells (39%; Fig. 8A). Therefore, Bex3 protein overexpression
enhanced the effect of NGF on the trkA promoter.
It has been described thatNGF increases Bex1 export from the
nucleus (Vilar et al., 2006). Bex3 also shuttles between cytoplasm
and nucleus (Mukai et al., 2000; Alvarez et al., 2005). To address
whether NGF alters Bex3 levels in the nucleus, we obtained nu-
clear fractions fromPC12-6/15 cells expressing endogenous Bex3
stimulated or not with NGF. Bex3 dimers were increased in the
nucleus of NGF-stimulated cells (Fig. 8B). Therefore, these data
suggest that NGF induces accumulation of Bex3 in the nucleus as
a dimer.
Discussion
Here we show that Bex3 protein specifically regulates TrkA pro-
tein expression by enhancing trkA promoter activity. Conse-
quently, Bex3 regulates the survival of NGF-dependent DRG
neurons and the differentiation of PC12 cells. These conclusions
are supported by several lines of experimental evidence, as fol-
lows: (1) a reduction in Bex3 levels using shRNA leads to a spe-
cific decrease inTrkA, but not TrkB, protein levels in neurons; (2)
the reduction in TrkA protein levels is paralleled by a decrease in
trkAmRNA; (3) the activity of the trkA promoter is directly reg-
ulated by Bex3 protein levels; (4) ChIP assays indicate that Bex3
associates with the trkA promoter; (5) NGF-induced trkA tran-
scription is enhanced and accompanied by Bex3 accumulation
and dimerization in the nucleus; and (6) Bex3 protein levels
modulate NGF-mediated signaling, neurite outgrowth, and
NGF-dependent survival.
The results presented here demonstrate that Bex3 protein spe-
cifically regulates TrkA protein levels, an effect that is mediated
via the modulation of trkA mRNA transcription. These data are
consistent with the coincident temporal expression patterns of
TrkA and Bex3 in developing sensory neurons (Fig. 2), which is
comparable to that observed for several transcription factors
known to influence trkA mRNA expression (Huang et al., 1999;
Lei et al., 2001; Ma et al., 2003). A puzzling result of Bex3 deple-
tion was that the decrease in trkA mRNA was 50% (Fig. 4B),
whereas TrkA protein levels decreased by 75% (Fig. 4A). This
result may be due to Bex3 having additional functions aside from
regulating trkA promoter activity. It has been reported that Bex3
associates with eIF3 protein (Tong et al., 2003), which plays an
important role in translation initiation; it is therefore possible
that Bex3 regulates trkA mRNA translation and that this may
contribute to the strong reduction in TrkA protein levels ob-
served when Bex3 is depleted.
The regulation of trkA promoter activity by the effect of Bex3
was addressed using gain-of-function and loss-of-function ex-
Figure 5. Bex3 shuttles between the cytoplasm and the nucleus. A, Subcellular localization
of GFP-Bex3protein inHEK293 cells. Cellswere transfectedwithGFP-Bex3 or GFP-Bex3 L90,93A
expression vectors. Nuclei were visualized with Hoechst 33342 stain. Note the accumulation of
GFP-Bex3 L90,93A in the nucleus.B, Bex3 protein is accumulated in the nucleus in the presence
of leptomycin B (LMB). HEK293 cells transfected with GFP-Bex3 or GFP-ARMS plasmids were
treated with LMB (5 ng/ml) for 6 h. Nuclei were visualized with Hoechst 33342 stain. Note the
nuclear accumulation of GFP-Bex3, but not of GFP-ARMS, upon LMB treatment. Scale bar, 20
m.
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periments. The overexpression of WT Bex3 resulted in an in-
crease in trkA promoter activity, whereas a reduction of
endogenous Bex3 impaired it. Other members of the Bex family,
such as Bex2 andBex4, have also been implicated in the transcrip-
tional regulation of different genes (Han et al., 2005; Chien et al.,
2008). We have identified the C terminus of Bex3 as a key region
for the regulation of the trkA promoter, as well as the trkA pro-
moter sequences close to the transcription start site through
which Bex3 acts. An unexpected result was that WT Bex3 and
mutants capable of enhancing the activation of the trkApromoter
formed oligomers, whereas Bex3 mutant proteins, unable to in-
crease trkA promoter activity, behaved as monomers. Bex3 is the
onlymember of Bex family that shows oligomerization (Mukai et
al., 2000; Alvarez et al., 2005). The direct correlation observed
between the ability of Bex3 mutant proteins to form oligomers
and to activate trkA promoter suggests that Bex3 oligomerization
is important for Bex3 functions. The increased activation of the
trkA promoter elicited by the overexpression of Bex3 C117S was
particularly remarkable. This mutation in Bex3 prevents lipid
modification, thus limiting anchoring of this mutant protein
to membranes (Kim et al., 2004). In addition, the Bex3 C117S-
impaired interaction with TrkA may facilitate its access to the
nucleus, promoting enhanced trkA transcription compared
with WT Bex3. In contrast, Bex3 C98S, which has been previ-
ously shown not to dimerize (Kimura et al., 2001), lacked any
increase in the transcriptional activity of trkA promoter (Fig.
6D). Thus, Bex3 dimerization is crucial to its function on the
trkA promoter.
The basal expression of trkA mRNA is regulated by several
different factors (Lei and Parada, 2007). To date, only HAND
transcription factors have been implicated in the expression of
trkAmRNA in response to NGF (Doxakis et al., 2008). The effect
mediated by HAND proteins is modest, suggesting the participa-
tion of additional proteins. Our results indicate for the first time
Figure 6. Bex3 dimerization potentiates the transcriptional activity of themouse trkA promoter. A, Bex3 depletion reducesmouse trkA promoter activity. Top, Experiments using N2a cells were
performed as described in Figure 3A upon infection with lentivirus-expressing control shRNA (c) and mouse Bex3 shRNA (b). Bottom, N2a cells were transfected with the reporter construct pMS8
together with control shRNA (c), Bex3 shRNA (b), or Bex3 shRNA GFP-Bex3-resistant (R) expression vectors. Data are shown as the mean SEM (100% vs 64.3 5.6%, control shRNA vs Bex3
shRNA, respectively); 100% vs 203 12.5%, control shRNA vs Bex3 shRNA GFP-Bex3-resistant expression vectors, respectively; n	 3–5 using duplicates). The p values were calculated using
a paired two-tailed Student’s t test. B, GFP-Bex3 expression increases the transcriptional activity of the mouse trkA promoter in N2a cells. Data are shown as the mean SEM (100% vs 188.7
16.9%, GFP vs GFP-Bex3, respectively; 188.7 16.9% vs 366 20.5%, GFP-Bex3 vs GFP-Bex3 C117S, respectively; n	 4–9 using duplicates). The p values were calculated using a paired
two-tailed Student’s t test. Note the increased trkA promoter activity induced by GFP-Bex3, GFP-Bex3 K89R, and GFP-Bex3 C117S protein, and the lack of effect on the trkA promoter upon GFP-Bex3
mutants L90,93A, D1, and D2 expression. C, Representative Western blot showing GFP-Bex3 protein expression in N2a transfected cells, in duplicate. Note the presence of monomers, dimers, and
tetramers of GFP-Bex3 proteins, indicated by arrows.D, Bex3 dimerization is required to enhance the transcriptional activity of the trkA promoter. Western blot showing the expression ofWT Bex3
and Bex3 C98S, which does not dimerize in N2a cells (left). Reporter assays were performed as described in A (right). Data are shown as the mean SEM (205 15.25% vs 123.6 10.34%,
GFP-Bex3 vs GFP-Bex3 C98S, respectively; n	 5 using duplicates). The p values were calculated using a paired two-tailed Student’s t test. Arrows indicate GFP-Bex3 monomers, dimers, and
tetramers. E, Bex3 overexpression increases neurite outgrowth of PC12 cells in response to NGF. Cells were transfected with plasmids expressing GFP, GFP-Bex3, GFP-Bex3 L90,93A, and GFP-Bex3
C98S, and the next day were stimulated with NGF (10 ng/ml) for 96 h. Neurite outgrowth was quantified as described in Figure 3D. Data are shown as the mean SEM. The percentage of
neurite-bearing cells versus the total number of cells scored in each case was 31.1% and 376 cells for GFP, 43.9% and 275 cells for GFP-Bex3, 35.7% and 281 cells for GFP-Bex3 L90,93A and 33.2%
and230 cells for GFP-Bex3 C98S. Thep valuewas calculatedusing apaired two-tailed Student’s t test.F, Overexpression of Bex3protein induces apoptosis of NGF-dependent sensory neurons in vitro.
Cultured DRG neurons were transfected with plasmids expressing GFP, GFP-Bex3, GFP-Bex3 L90,93A, and GFP-Bex3 C98S. Apoptotic neurons were quantified as described in Figure 3C. Data are
shown as themean SEM. The percentage of apoptotic cells versus the total number of cells scored in each casewas 36.0% and 257 cells for GFP, 56.0% and 127 cells for GFP-Bex3, 35.6% and 142
cells for GFP-Bex3 L90,93A, and 58.1% and 120 cells for GFP-Bex3 C98S. The p value was calculated using a paired two-tailed Student’s t test.
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that Bex3 enhances both the basal tran-
scriptional activation of the trkA pro-
moter as well as the NGF-mediated
upregulation of trkA mRNA levels. Fur-
thermore, Bex3 expression is enhanced by
NGF treatment in oligodendrocytes (Mu-
kai et al., 2000), and NGF modulates the
expression of different genes, including
several transcription factors (Yang et al.,
2013). It is tempting to speculate that
NGF would first increase Bex3 protein
levels and dimerization, and that Bex3
would subsequently act on the trkA
promoter.
Howdoes Bex3 shuttle between the cy-
toplasm and the nucleus? It has been re-
ported that Bex1 ismainly accumulated in
the nucleus (Alvarez et al., 2005; Vilar et
al., 2006), but in cells expressing p75, and
in response toNGF, Bex1 rapidly relocates
from the nucleus to the cytoplasm (Vilar
et al., 2006). By contrast, Bex3 is mainly
located in the cytoplasm (Fig. 5; Mukai et
al., 2000; Alvarez et al., 2005). Bex3 traf-
fickingmay be controlled by the following
different mechanisms: (1) Bex3 is effi-
ciently excluded from the nucleus via the
NES motif (Mukai et al., 2000; Alvarez et
al., 2005; Fig. 5); (2) Bex3 interacts with
14-3-3 (Kimura et al., 2001), andhence it
is possible that 14-3-3 binding might ex-
clude Bex3 from the nucleus, whereas in
response to different stimuli Bex3 is re-
leased and enters the nucleus (it has been
reported that 14-3-3 proteins sequester
c-Abl in the cytosol, and in response to
genotoxic agents 14-3-3 is phosphory-
lated and releases c-Abl, which translo-
cates to the nucleus; Yoshida et al., 2005);
(3) our results indicating that Bex3 C117S
elicited a higher transcriptional activity of
the trkApromoter thanWTBex3 (Fig. 6B)
suggest thatWTBex3may be kept outside
of the nucleus because it is attached to
membranes, where it can easily interact
with Trk receptors; therefore, the binding
of TrkA to Bex3might regulate Bex3 func-
tion on the trkApromoter; and (4) aNGF-
dependent interaction of Bex3 with p75
has been described in oligodendrocytes
(Mukai et al., 2000), and it is known that,
upon cleavage, the intracellular domain
(ICD) of p75 enters the nucleus in re-
sponse to NGF (Kanning et al., 2003;
Frade, 2005). Accordingly, it is possible
that Bex3 translocates into the nucleus as-
sociated with p75 ICD. Additional exper-
iments will be required to address these
questions.
A consequence of Bex3 increasing trkA mRNA expression is
the regulation of NGF-mediated signaling, and hence neuronal
survival and differentiation, which are dependent on the NGF/
TrkA system during development. In agreement with this, the
overexpression of WT Bex3, but not a mutant that is mainly
nuclear (Bex3 L90,93A) or amutant that does not dimerize (Bex3
C98S), enhances neurite outgrowth (Fig. 6E). This supports the
idea that nuclear–cytoplasmic shuttling and dimerization of
Figure 7. Bex3 increases themouse trkA gene promoter activity and binds close to the transcriptional start site.A, Mapping the
region of themouse trkA promotermodulated by GFP-Bex3. The transcriptional activities of different reporter plasmids containing
different sequences from the 5 region of themouse trkA promoter (top) are shown. Data are presented as themean SEM. Data
are reported as GFP versus GFP-Bex3, respectively (100% vs 188.7 16.9%, for pMS8; 99.95 28.75% vs 214.8 19.01%, for
pMS10.3; 113.7 28.75% vs 196.2 20.49%, for pMS16; 14.05 2.2% vs 16.54 3.17%, for pMS22; n	 4–9 using
duplicates). Thep valueswere calculatedusingapaired two-tailed Student’s t test.B, EndogenousBex3proteinbinds to themouse
trkA promoter in N2a cells. ChIP analysis of N2a cell lysates using anti-Bex3-ProtG-agarose. Goat IgG-ProtG-agarose was used as a
control. A representative experiment is shown (n	 5). C, Quantitative ChIP assays in PC12 cells. Cell lysateswere immunoprecipi-
tatedusing theanti-Bex3-ProtG-agaroseor goat IgG-ProtG-agarose as a control. qPCRswereperformedusing theoligonucleotides
described in Materials and Methods. The p value was calculated using a two-tailed Student’s t test (n	 3 by triplicate).
Figure 8. Bex3 enhances NGF-mediated trkA promoter activity.A, Enhanced NGF-mediated trkA promoter activity by Bex3 overexpression.
PC12cellsweretransfectedwiththefollowingplasmids: reporterconstructpMS8andGFPorGFP-Bex3.Onthefollowingday,cellsweretreated,or
not,withNGF (100ng/ml) for0.5and18h,and reporterassayswereperformedwithall samples inparallel.Dataare shownas themeanSEM
(100%vs16013.58%,GFPvsGFP-Bex3, respectively;100%vs121.79.94%,noNGFvs18hNGF, respectively;16013.58%vs222.3
27.91%,noNGFvs18hNGF,respectively;n	3usingduplicates).Thepvalueswerecalculatedusingapairedtwo-tailedStudent’s t test.Notethe
significantincreasein trkApromoteractivityinsamplesexpressingGFP-Bex3treatedwithNGFfor18h.B,Bex3dimersaccumulateinthenucleusin
responsetoNGF.EndogenousBex3wasmonitoredbyWesternblotinnuclearfractionsofPC12–6/15cellsstimulated,ornot,withNGF(100ng/ml)
for15min.Phospho-Histone3(pH3)wasusedasanuclearmarker.ArrowsindicateBex3monomersanddimers.
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Bex3 are crucial events in promoting neurite outgrowth. Inter-
estingly, the overexpression of WT Bex3 or Bex3 C98S, but not
Bex3 L90,93A, enhances the apoptosis of sensory neurons that
occurs in response to NGF deprivation (Fig. 6F). This might be
explained by the effects of Bex3 expression inducing apoptosis
through p75 neurotrophin receptor that have been previously
reported (Mukai et al., 2000, 2002; Kimura et al., 2001). Under
pathological conditions, TrkA expression has been proposed to
be a predictive marker of favorable outcome in low-stage neuro-
blastomas, leading to enhanced patient survival and terminal
neuronal differentiation in the presence of NGF or apoptosis in
the absence of NGF, whereas TrkA expression is low or absent in
most advanced-stage tumors, which do not undergo differentia-
tion or regression (Brodeur et al., 2009). On the other hand, it has
been reported that trkA mRNA levels are strongly reduced in
different areas of postmortem brains of patients with AD (Bois-
siere et al., 1997; Hock et al., 1998). The reduced expression of
TrkA contributes to impaired NGF signaling and a decreased
retrograde transport of NGF in cholinergic neurons in the basal
forebrain and striatum. Future studies should determine the lev-
els of Bex3 in different neuroblastoma cell lines and in samples
from AD patients to assess the possible roles of Bex3 in these
disease states.
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